Compounds > amlodipine

amlodipine and azilsartan

amlodipine has been researched along with azilsartan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagawa, T; Nakata, E; Rakugi, H; Sasaki, E1
Hoshide, S; Kario, K2
Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Umeda, Y1
Kinugawa, Y; Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Terashio, S1

Trials

5 trial(s) available for amlodipine and azilsartan

ArticleYear
Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension.
    Clinical therapeutics, 2014, Volume: 36, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Asian People; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Male; Middle Aged; Oxadiazoles

2014
Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:4

    Topics: Administration, Oral; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Oxadiazoles; Sleep; Treatment Outcome

2015
Age- and Sex-Related Differences in Efficacy With an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensive Patients.
    Journal of clinical hypertension (Greenwich, Conn.), 2016, Volume: 18, Issue:7

    Topics: Age Factors; Aged; Amlodipine; Angiotensin Receptor Antagonists; Asian People; Benzimidazoles; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Oxadiazoles; Sex Characteristics; Treatment Outcome

2016
A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.
    Blood pressure, 2018, Volume: 27, Issue:3

    Topics: Adult; Aged; Amlodipine; Benzimidazoles; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Oxadiazoles

2018
Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.
    Blood pressure monitoring, 2018, Volume: 23, Issue:2

    Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Japan; Male; Middle Aged; Oxadiazoles; Treatment Outcome

2018